Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
15 Patents
#154 in Atlanta, GA
#406 in Georgia
#21,068 in US
#39,959 in the World
Celtaxsys, Inc.
Forward Citations = 63
28 inventors:
Atlanta, GA, United States of America
Celtaxsys, Inc.
Calculating rank
% Expired Patents = 40.0
EPO Patents = 1
Trademarks = 1
Forward Citations = 63
Loading Chart...
Loading Chart...
28 inventors (with patents filed for the assignee):
William J Guilford (10 out of 39 patents)
Lopa Bhatt (7 out of 8 patents)
Eric B Springman (5 out of 9 patents)
4. Kurt Roinestad (3 out of 3 patents)
5. Tom Kirkland (3 out of 3 patents)
6. David D Davey (3 out of 43 patents)
7. Greg Brown (2 out of 5 patents)
8. Emmanuel Claret (2 out of 5 patents)
9. Arwed Cleve (2 out of 28 patents)
10. Seock-Kyu Khim (2 out of 7 patents)
11. Monica J Kochanny (2 out of 27 patents)
12. Amy Liang (2 out of 5 patents)
13. Guo Ping Wei (2 out of 20 patents)
14. Bin Ye (2 out of 22 patents)
15. Margaret McCrann Pugh (2 out of 3 patents)
15 patents:
3. 10385007 - Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase (2019-08-20),
Company Overview
Celtaxsys, Inc. is a biotechnology company based in Atlanta, Georgia, focused on developing innovative therapies for chronic inflammatory diseases. The organization specializes in harnessing advanced biological research to create solutions that address unmet medical needs, particularly in the fields of immunology and inflammation. By leveraging cutting-edge technology and scientific expertise, Celtaxsys aims to improve patient outcomes and enhance the quality of life for individuals affected by these conditions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celtaxsys, Inc.. Retrieved from https://idiyas.com/company/celtaxsys
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]